Comparison of magnetic resonance imaging and ultrasound ( MRI‐US ) fusion‐guided prostate biopsies obtained from axial and sagittal approaches
Open Access
- 21 July 2014
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 115 (5) , 772-779
Abstract
Objective: To compare cancer detection rates and concordance between magnetic resonance imaging and ultrasound ( MRI‐US ) fusion‐guided prostate biopsy cores obtained from axial and sagittal approaches. Patients and Methods: Institutional records of MRI‐US fusion‐guided biopsy were reviewed. Detection rates for all cancers, G leason ≥3 + 4 cancers, and G leason ≥4 + 3 cancers were computed. Agreement between axial and sagittal cores for cancer detection, and frequency where one was upgraded the other was computed on a per‐target and per‐patient basis. Results: In all, 893 encounters from 791 patients that underwent MRI‐US fusion‐guided biopsy in 2007–2013 were reviewed, yielding 4688 biopsy cores from 2344 targets for analysis. The mean age and PSA level at each encounter was 61.8 years and 9.7 ng/mL (median 6.45 ng/mL). Detection rates for all cancers, ≥3 + 4 cancers, and ≥4 + 3 cancers were 25.9%, 17.2%, and 8.1% for axial cores, and 26.1%, 17.6%, and 8.6% for sagittal cores. Per‐target agreement was 88.6%, 93.0%, and 96.5%, respectively. On a per‐target basis, the rates at which one core upgraded or detected a cancer missed on the other were 8.3% and 8.6% for axial and sagittal cores, respectively. Even with the inclusion of systematic biopsies, omission of axial or sagittal cores would have resulted in missed detection or under‐characterisation of cancer in 4.7% or 5.2% of patients, respectively. Conclusion: Cancer detection rates, G leason scores, and core involvement from axial and sagittal cores are similar, but significant cancer may be missed if only one core is obtained for each target. Discordance between axial and sagittal cores is greatest in intermediate‐risk scenarios, where obtaining multiple cores may improve tissue characterisation.Keywords
Funding Information
- National Institutes of Health
This publication has 31 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Targeted Biopsy in the Detection of Prostate Cancer Using an Office Based Magnetic Resonance Ultrasound Fusion DeviceJournal of Urology, 2013
- Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound BiopsiesJournal of Urology, 2012
- Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy Improves Cancer Detection Following Transrectal Ultrasound Biopsy and Correlates With Multiparametric Magnetic Resonance ImagingJournal of Urology, 2011
- D'Amico Risk Stratification Correlates With Degree of Suspicion of Prostate Cancer on Multiparametric Magnetic Resonance ImagingJournal of Urology, 2011
- Is Apparent Diffusion Coefficient Associated with Clinical Risk Scores for Prostate Cancers that Are Visible on 3-T MR Images?Radiology, 2011
- Prostate Cancer: Value of Multiparametric MR Imaging at 3 T for Detection—Histopathologifc CorrelationRadiology, 2010
- Imaging techniques for prostate cancer: implications for focal therapyNature Reviews Urology, 2009
- The Relationship of Prostate Gland Volume to Extended Needle Biopsy on Prostate Cancer DetectionJournal of Urology, 2003
- IMPACT OF TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY ON QUALITY OF LIFE: A PROSPECTIVE RANDOMIZED TRIAL COMPARING 6 VERSUS 12 CORESJournal of Urology, 2001